Cerevel Therapeutics Holdings(CERE.US)董事售出5万股普通股股份,价值约203.05万美元

Cerevel Therapeutics Holdings(CERE.US) Director Sells US$2.03 Million in Common Stock

Futu News ·  Jun 6 04:45

$Cerevel Therapeutics Holdings (CERE.US)$ Director COLES N ANTHONY sold 50,000 shares of common stock on Jun 3, 2024 at an average price of $40.6104 for a total value of $2.03 million.


What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment